Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CPI-360 is a small molecule EZH2 inhibitor (IC50: 0.002 μM, EC50: 0.080 μM) that shows antitumor activity in an EZH200-dependent tumor xenograft model.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 76.00 | |
5 mg | In stock | $ 175.00 | |
10 mg | In stock | $ 285.00 | |
25 mg | In stock | $ 478.00 | |
50 mg | In stock | $ 687.00 | |
100 mg | In stock | $ 998.00 |
Description | CPI-360 is a small molecule EZH2 inhibitor (IC50: 0.002 μM, EC50: 0.080 μM) that shows antitumor activity in an EZH200-dependent tumor xenograft model. |
Targets&IC50 | EZH1:102.3 nM |
In vitro | In KARPAS-422 cells, CPI-360 potently reduces global H3K27me3 and H3K27me2 levels with EC50 of 56 nM and 65 nM, respectively. CPI-360 also causes time-dependent transcriptional changes, and affects the viability of Y641N mutant EZH2-containing KARPAS-422 cells. In addition, CPI-360 gradually arrests KARPAS-422 cells in the G1 cell cycle stage followed by the induction of apoptosis. [1] |
In vivo | In mice bearing KARPAS-422 xenografts, CPI-360 (200 mg/kg, s.c.) reduces tumor growth by 44%. [1] |
Synonyms | Synonym 2, CPI 360, CPI360 |
Molecular Weight | 437.53 |
Formula | C25H31N3O4 |
CAS No. | 1802175-06-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (51.4 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMF: 9.0 mg/mL (20.6 mM)
Ethanol: 27.0 mg/mL (61.7 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CPI-360 1802175-06-9 Apoptosis Chromatin/Epigenetic Histone Methyltransferase Synonym 2 CPI 360 CPI360 inhibitor inhibit